DAFNA Capital Management as of March 31, 2022
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 94 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis Com New (STXS) | 13.3 | $51M | 14M | 3.73 | |
| Spdr Sp Biotech Etf Etf (XBI) | 6.3 | $24M | 270k | 89.88 | |
| Fate Therapeutics (FATE) | 5.1 | $19M | 501k | 38.77 | |
| Blueprint Medicines (BPMC) | 4.1 | $16M | 246k | 63.88 | |
| Adicet Bio (ACET) | 3.7 | $14M | 716k | 19.97 | |
| Ishares Tr Nasdaq Biotech Indx Etf (IBB) | 3.5 | $13M | 103k | 130.30 | |
| Xenon Pharmaceuticals (XENE) | 3.0 | $12M | 380k | 30.57 | |
| Karuna Therapeutics Ord | 2.7 | $10M | 82k | 126.78 | |
| Dex (DXCM) | 2.4 | $9.3M | 18k | 511.58 | |
| Biohaven Pharmaceutical Holding | 2.4 | $9.2M | 78k | 118.57 | |
| Neurocrine Biosciences (NBIX) | 2.0 | $7.8M | 84k | 93.75 | |
| Cytokinetics Com New (CYTK) | 2.0 | $7.8M | 212k | 36.81 | |
| Nurix Therapeutics (NRIX) | 2.0 | $7.6M | 543k | 14.01 | |
| Morphic Hldg (MORF) | 1.9 | $7.3M | 182k | 40.15 | |
| Cardiovascular Systems | 1.7 | $6.5M | 287k | 22.60 | |
| Syndax Pharmaceuticals (SNDX) | 1.7 | $6.5M | 372k | 17.38 | |
| Merus N V (MRUS) | 1.6 | $6.2M | 235k | 26.44 | |
| Sage Therapeutics (SAGE) | 1.6 | $6.0M | 180k | 33.10 | |
| Revolution Medicines (RVMD) | 1.5 | $5.9M | 232k | 25.51 | |
| Ideaya Biosciences (IDYA) | 1.4 | $5.5M | 490k | 11.19 | |
| Cymabay Therapeutics | 1.4 | $5.3M | 1.7M | 3.11 | |
| Iveric Bio | 1.3 | $5.0M | 299k | 16.83 | |
| Natus Medical | 1.3 | $5.0M | 191k | 26.28 | |
| Apellis Pharmaceuticals (APLS) | 1.2 | $4.8M | 94k | 50.81 | |
| AtriCure (ATRC) | 1.2 | $4.7M | 72k | 65.67 | |
| Arcus Biosciences Incorporated (RCUS) | 1.2 | $4.6M | 145k | 31.56 | |
| Alector (ALEC) | 1.1 | $4.2M | 293k | 14.25 | |
| Radius Health Note 3.000% 9/0 (Principal) | 1.0 | $3.9M | 4.0M | 0.97 | |
| Otonomy | 0.9 | $3.6M | 1.5M | 2.40 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.9 | $3.6M | 31k | 117.37 | |
| Mirati Therapeutics | 0.9 | $3.5M | 43k | 82.22 | |
| Edgewise Therapeutics (EWTX) | 0.9 | $3.5M | 357k | 9.70 | |
| Century Therapeutics (IPSC) | 0.8 | $3.2M | 257k | 12.59 | |
| Accuray Incorporated (ARAY) | 0.8 | $3.1M | 942k | 3.31 | |
| Pardes Biosciences | 0.8 | $3.0M | 421k | 7.22 | |
| Field Trip Health Ord | 0.8 | $2.9M | 2.2M | 1.34 | |
| Iteos Therapeutics (ITOS) | 0.7 | $2.9M | 89k | 32.18 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $2.8M | 191k | 14.74 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.7 | $2.7M | 896k | 2.99 | |
| Galapagos Nv Spon Adr (GLPG) | 0.7 | $2.6M | 43k | 62.03 | |
| Axogen (AXGN) | 0.7 | $2.6M | 332k | 7.94 | |
| Aerie Pharmaceuticals | 0.7 | $2.6M | 289k | 9.10 | |
| Affimed Therapeutics B V | 0.7 | $2.5M | 571k | 4.37 | |
| F-star Therapeutics | 0.6 | $2.5M | 694k | 3.55 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $2.3M | 53k | 43.87 | |
| Athira Pharma (ATHA) | 0.6 | $2.2M | 161k | 13.50 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.5 | $2.1M | 496k | 4.17 | |
| Surface Oncology | 0.5 | $2.0M | 680k | 2.94 | |
| Kura Oncology (KURA) | 0.5 | $1.8M | 113k | 16.08 | |
| Dice Therapeutics | 0.5 | $1.8M | 94k | 19.13 | |
| Brainsway Sponsored Ads (BWAY) | 0.5 | $1.7M | 200k | 8.73 | |
| Biomea Fusion (BMEA) | 0.4 | $1.7M | 384k | 4.46 | |
| Radius Health Com New | 0.4 | $1.7M | 192k | 8.83 | |
| Macrogenics (MGNX) | 0.4 | $1.7M | 192k | 8.81 | |
| Cogent Biosciences (COGT) | 0.4 | $1.7M | 224k | 7.49 | |
| Kinnate Biopharma (KNTE) | 0.4 | $1.7M | 148k | 11.26 | |
| Regulus Therapeutics Com New | 0.4 | $1.7M | 5.6M | 0.30 | |
| Ngm Biopharmaceuticals (NGM) | 0.4 | $1.6M | 108k | 15.25 | |
| Immunocore Holdings Ads (IMCR) | 0.4 | $1.6M | 54k | 29.90 | |
| Turning Point Therapeutics I | 0.4 | $1.6M | 60k | 26.85 | |
| Mersana Therapeutics (MRSN) | 0.4 | $1.4M | 353k | 3.99 | |
| Venus Concept | 0.4 | $1.4M | 968k | 1.43 | |
| Mereo Biopharma Group Ads (MREO) | 0.4 | $1.4M | 1.2M | 1.12 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 0.4 | $1.3M | 1.5M | 0.90 | |
| Viking Therapeutics (VKTX) | 0.3 | $1.3M | 447k | 3.00 | |
| 89bio (ETNB) | 0.3 | $1.2M | 324k | 3.77 | |
| Mei Pharma Com New | 0.3 | $1.1M | 1.8M | 0.60 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $1.0M | 55k | 18.29 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.3 | $965k | 75k | 12.89 | |
| Neuronetics (STIM) | 0.2 | $951k | 314k | 3.03 | |
| Theseus Pharmaceuticals | 0.2 | $924k | 80k | 11.53 | |
| Nextcure (NXTC) | 0.2 | $912k | 188k | 4.86 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $869k | 314k | 2.77 | |
| Wave Life Sciences SHS (WVE) | 0.2 | $780k | 390k | 2.00 | |
| Genfit S A Ads (GNFT) | 0.2 | $752k | 188k | 4.00 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $723k | 351k | 2.06 | |
| Vigil Neuroscience (VIGL) | 0.2 | $701k | 100k | 7.03 | |
| Sutro Biopharma (STRO) | 0.2 | $696k | 85k | 8.22 | |
| Pharvaris N V (PHVS) | 0.2 | $628k | 35k | 18.14 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.2 | $613k | 139k | 4.40 | |
| Harpoon Therapeutics | 0.1 | $523k | 105k | 4.97 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.1 | $500k | 379k | 1.32 | |
| Inogen (INGN) | 0.1 | $486k | 15k | 32.40 | |
| Scynexis Com New (SCYX) | 0.1 | $474k | 121k | 3.91 | |
| Masimo Corporation (MASI) | 0.1 | $437k | 3.0k | 145.67 | |
| Compugen Ord (CGEN) | 0.1 | $419k | 130k | 3.22 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $304k | 3.1k | 98.06 | |
| Compass Therapeutics (CMPX) | 0.1 | $269k | 196k | 1.37 | |
| Aslan Pharmaceuticals Ads | 0.1 | $219k | 244k | 0.90 | |
| Lineage Cell Therapeutics In (LCTX) | 0.1 | $216k | 140k | 1.54 | |
| Larimar Therapeutics (LRMR) | 0.1 | $202k | 50k | 4.04 | |
| Rti Biologics | 0.0 | $176k | 580k | 0.30 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $137k | 120k | 1.14 | |
| Annexon (ANNX) | 0.0 | $84k | 31k | 2.73 |
